|
|||||
|
|
Variation in treatment associated with life expectancy in a population‐based cohort of men with early‐stage prostate cancer |
|
| Authors: | Timothy J. Daskivich MD MSHPM Julie Lai MPH Andrew W. Dick PhD Claude M. Setodji PhD Janet M. Hanley MS Mark S. Litwin MD MPH Christopher Saigal MD MPH |
| Affiliation: | 1. Department of Urology, David Geffen School of Medicine, University of California‐Los Angeles, Los Angeles, California;2. RAND Corporation, Santa Monica, California;3. Department of Health Policy and Management, Fielding School of Public Health, University of California‐Los Angeles, Los Angeles, California |
| Abstract: | |
| Keywords: | life expectancy survival comorbidity outcomes prostate adenocarcinoma |